BioCentury
ARTICLE | Distillery Therapeutics

Neurology

September 26, 2018 5:39 PM UTC

Cell culture and mouse studies suggest inhibiting Rho kinase could help to treat AD. In primary rat cortical neurons stimulated with DKK1 to produce β amyloid, the Rho kinase inhibitor Eril fasudil increased dendritic spine numbers and decreased β amyloid levels compared with no treatment. In a mouse model of AD, Eril decreased levels of β amyloid and plaque area in the cortex and hippocampus compared with vehicle. Next steps could include testing Rho kinase inhibition in additional models of AD...

BCIQ Company Profiles

King's College London